TherapeuticsMD Up 40% After Mixed Q3, Plans To Resubmit NDA For TX-004HR

By: via Benzinga
TherapeuticsMD Inc (NASDAQ: TXMD) shares are trading higher by $1.79 (39.8 percent) at $6.15 in Monday's session. Before the open, ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.